Kyowa Hakko Kirin Of Japan To Team With University For ATL Drug
This article was originally published in PharmAsia News
Executive Summary
Japan's Kyowa Hakko Kirin reportedly plans to collaborate with Nagoya City University to develop a drug to treat adult T-cell leukemia